X

Vous n'êtes pas connecté

Maroc Maroc - PHARMABIZ.COM - A la Une - 20/Sep 08:15

MyOme expands rare disease test with new genome insights

Menlo Park─based MyOme, a clinical whole genome analysis company helping families understand their risk for diseases, has announced the expansion of its rare disease test to include tandem repeat expansions

Articles similaires

How a Simple Blood Test Can Estimate Cirrhosis Risk

medindia.net - 30/Sep 14:50

Researchers demonstrated a bnew blood test, CORE (Cirrhosis Outcome Risk Estimator) method for severe liver disease prognosis. This simple blood...

Sorry! Image not available at this time

Worldwide Clinical Trials - USA: Senior Clinical Research Associate - CNS/Rare Disease - Northeast

pharmiweb.com - 05/Oct 00:00

Competitive: Worldwide Clinical Trials - USA: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path...

Sorry! Image not available at this time

Worldwide Clinical Trials - USA: Senior Clinical Research Associate - CNS/Rare Disease - Northeast

pharmiweb.com - 05/Oct 00:00

Competitive: Worldwide Clinical Trials - USA: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path...

Sorry! Image not available at this time

ICON Plc: Clinical Trial Manager - CNS/Rare Diseases

pharmiweb.com - 00:00

Competitive: ICON Plc: Clinical Trial Manager - CNS/Rare Diseases ICON plc is a world-leading healthcare intelligence and clinical research...

Whole genome sequencing may guide care for thousands of breast cancer patients

news.medical.net - 02:34

Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or...

Huntington's Disease Successfully Treated for the First Time

thecekodok.com - 25/Sep 10:43

Huntington's disease is an inherited genetic disease, causing progressive damage to certain nerve cells in the brain. This damage worsens over time...

Sorry! Image not available at this time

JCR Pharmaceuticals Announces Licensing Agreement with Menagen to Commercialize Agalsidase Beta BS I.V. Infusion [JCR] Across Nine MENAT Markets

wn.com - 01/Oct 21:29

HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to...

Sorry! Image not available at this time

Student Transportation of America Achieves $100M+ in Growth as Strategic Acquisitions and Market Expansions Accelerate

wn.com - 03/Oct 07:58

Company Expands Service Footprint Across U.S. and Canada, Enters New States, and Strengthens Employee Transportation Offerings ......

Sorry! Image not available at this time

Student Transportation of America Achieves $100M+ in Growth as Strategic Acquisitions and Market Expansions Accelerate

wn.com - 03/Oct 17:44

Company Expands Service Footprint Across U.S. and Canada, Enters New States, and Strengthens Employee Transportation Offerings ......

Sorry! Image not available at this time

Student Transportation of America Achieves $100M+ in Growth as Strategic Acquisitions and Market Expansions Accelerate

wn.com - 03/Oct 09:42

Company Expands Service Footprint Across U.S. and Canada, Enters New States, and Strengthens Employee Transportation Offerings ......